169 related articles for article (PubMed ID: 11455764)
21. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
22. Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study.
Klimberg I; Shockey G; Ellison H; Fuller-Jonap F; Colgan R; Song J; Keating K; Cyrus P
Curr Med Res Opin; 2005 Aug; 21(8):1241-50. PubMed ID: 16083534
[TBL] [Abstract][Full Text] [Related]
23. [Study on clinical effects of tosufloxacin (TFLX) and the long-term low dose therapy for the prophylaxis of recurrent urinary tract infection].
Sakurai M; Sugimura Y; Arima K; Kawamura J; Saitou K; Tajima K; Nakano S; Satani H; Nagano M; Hoshina A
Hinyokika Kiyo; 1994 Mar; 40(3):279-84. PubMed ID: 8178752
[TBL] [Abstract][Full Text] [Related]
24. Uncomplicated urinary tract infections. Bacterial findings and efficacy of empirical antibacterial treatment.
Grude N; Tveten Y; Jenkins A; Kristiansen BE
Scand J Prim Health Care; 2005 Jun; 23(2):115-9. PubMed ID: 16036551
[TBL] [Abstract][Full Text] [Related]
25. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
26. One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study.
Sofikerim M; Gülmez I; Karacagil M
BJU Int; 2007 Feb; 99(2):466. PubMed ID: 17313438
[No Abstract] [Full Text] [Related]
27. Tolerance and pharmacokinetics of ciprofloxacin in the chick. Preliminary experience in subjects of pediatric age with urinary tract infections (UTI).
Naccari F; Salpietro DC; De Sarro A; Masaracchio A; Barberi I
Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):187-92. PubMed ID: 9583092
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of uncomplicated urinary tract infections.
Mehnert-Kay SA
Am Fam Physician; 2005 Aug; 72(3):451-6. PubMed ID: 16100859
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for a poor outcome after therapy for acute pyelonephritis.
Pertel PE; Haverstock D
BJU Int; 2006 Jul; 98(1):141-7. PubMed ID: 16831159
[TBL] [Abstract][Full Text] [Related]
30. Follow-up therapy with ciprofloxacin in severe infection, an alternative to parenteral treatment.
Bassaris HP; Chrysanthopoulos CJ; Skouelis AT; Starakis JC
J Chemother; 1989 Jul; 1(4 Suppl):676-7. PubMed ID: 16312588
[No Abstract] [Full Text] [Related]
31. An elderly patient with fluoroquinolone-associated achilles tendinitis.
Damuth E; Heidelbaugh J; Malani PN; Cinti SK
Am J Geriatr Pharmacother; 2008 Dec; 6(5):264-8. PubMed ID: 19161929
[TBL] [Abstract][Full Text] [Related]
32. A pilot randomized double-blind placebo-controlled trial on the use of antibiotics on urinary catheter removal to reduce the rate of urinary tract infection: the pitfalls of ciprofloxacin.
Wazait HD; Patel HR; van der Meulen JH; Ghei M; Al-Buheissi S; Kelsey M; Miller RA; Emberton M
BJU Int; 2004 Nov; 94(7):1048-50. PubMed ID: 15541126
[TBL] [Abstract][Full Text] [Related]
33. [7-day therapy of urinary tract infection using low-dose ciprofloxacin].
Prát V; Horcicková M; Matousovic K; Hatala M; Milotová Z
Cas Lek Cesk; 1988 Mar; 127(13):406-8. PubMed ID: 3365743
[No Abstract] [Full Text] [Related]
34. Increased treatment failure after 3-days' courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database.
Goettsch WG; Janknegt R; Herings RM
Br J Clin Pharmacol; 2004 Aug; 58(2):184-9. PubMed ID: 15255801
[TBL] [Abstract][Full Text] [Related]
35. Natural history of urinary tract infection in a primary care environment in Canada.
Nickel JC; Lee JC; Grantmyre JE; Polygenis D
Can J Urol; 2005 Aug; 12(4):2728-37. PubMed ID: 16197596
[TBL] [Abstract][Full Text] [Related]
36. [Ciprofloxacin in the treatment of chronic urinary tract infections].
Sozzo E; Patruno P; Mastrangelo F
Clin Ter; 1988 Mar; 124(5):363-8. PubMed ID: 2974346
[No Abstract] [Full Text] [Related]
37. Effect of oral ciprofloxacin on fecal bacteria in elderly patients.
Höffler U; Grünig F; Brehmer B
J Chemother; 1989 Jul; 1(4 Suppl):617-8. PubMed ID: 16312558
[No Abstract] [Full Text] [Related]
38. [Efficacy of ciprofloxacine antibiotic prophylaxis of infectious complications after TUR of the prostate].
Rafal'skiĭ VV; Strachunskiĭ LS; Kogan MI; Petrov SB; Grinev AV; Veliev EI; Kopylov VV; Iskorostinskiĭ EV; Kirekhin IV
Urologiia; 2005; (5):21-5. PubMed ID: 16281834
[TBL] [Abstract][Full Text] [Related]
39. Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture.
Nys S; van Merode T; Bartelds AI; Stobberingh EE
J Antimicrob Chemother; 2006 May; 57(5):955-8. PubMed ID: 16554337
[TBL] [Abstract][Full Text] [Related]
40. Bay o 9867 (ciprofloxacin) in the treatment of urinary tract infections in elderly patients.
Vellucci A; De Rosa F; Bernardini G; Di Vico B
Riv Eur Sci Med Farmacol; 1988 Aug; 10(4):333-9. PubMed ID: 3274909
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
